-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
KalVista Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q1 2024.
- KalVista Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending April 30, 2024 was -1.06 USD/shares, a 43.2% decline year-over-year.
- KalVista Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending April 30, 2024 was -3.44 USD/shares, a 3.3% decline year-over-year.
- KalVista Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -3.44 USD/shares, a 3.3% decline from 2022.
- KalVista Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -3.33 USD/shares, a 0.89% increase from 2021.
- KalVista Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -3.36 USD/shares, a 38.8% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)